About
Neurostimulation therapy
Areas of Focus
Categories
Uncategorized Medical DeviceBoston & New England
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
3
As Collaborator
2
Total Enrollment
118
By Phase
NA: 4PHASE1/PHASE2: 1
By Status
COMPLETED: 3RECRUITING: 1TERMINATED: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06649955Lead Sponsor
Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study
NARecruiting
15 participants
Started: Feb 10, 2025 · Completed: Nov 30, 2026
NCT06165172Lead Sponsor
Early Feasibility Study of the MyoRegulator® for Treatment of ALS
NACompleted
5 participants
Started: Jun 21, 2023 · Completed: Aug 31, 2024
NCT04742257Lead Sponsor
Study Evaluating MyoRegulator® Treatment in Post-Stroke Upper Limb Spasticity
NATerminated
28 participants
Started: Mar 4, 2022 · Completed: Jun 30, 2024
NCT04780191Collaborator
Investigation of Treatment Using the MyoRegulator® Device in Patients With Spasticity in the Lower Limb Due to Stroke
NACompleted
44 participants
Started: Jul 19, 2018 · Completed: Jan 19, 2021
NCT03080454Collaborator
The Role of Trans-spinal Direct Current Stimulation (tsDCS) in Treating Patients With Hand Spasticity After Stroke
PHASE1/PHASE2Completed
26 participants
Started: Sep 30, 2016 · Completed: Mar 31, 2018
Locations (1)
Headquarters
Boston, MA, United States
Map
Loading map...